Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|8|599-625

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.8, 2003-03, pp. : 599-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Sodium-Dependent Glucose Co-Transporter 2 Inhibitors as Potential Anti-Diabetic Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1476-1512

Bentham Science Publishers

Access to resources Recommend Favorite

L-Type Voltage-Dependent Calcium Channels As Therapeutic Targets for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4816-4827

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 669-678

Bentham Science Publishers

Access to resources Recommend Favorite

High-affinity inhibition of glutamate release from corticostriatal synapses by -agatoxin TK

By Barral J.   Poblette F.   Mendoza E.   Pineda J.C.   Galarraga E.   Bargas J.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases

By St-Pierre Yves   Couillard Julie   Van Themsche Céline  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 473-489

Informa Healthcare

Access to resources Recommend Favorite